Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia

Annals of Hematology

Volumn 93, Issue 7, 2014, Pages 1123-1129

  Domingos, Igor F ^a,b   Falcão, Diego A ^a   Hatzlhofer, Betania L ^a,b   Cunha, Anderson F ^c   Santos, Magnun N ^d   Albuquerque, Dulcinéia M ^d   Fertrin, Kleber Y ^d   Costa, Fernando F ^d   Azevedo, Renata C ^b   Machado, Cíntia G ^b   Araújo, Aderson S ^b   Lucena Araujo, Antonio R ^a   Bezerra, Marcos A ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Haematology and Haemotherapy Foundation of Pernambuco (HEMOPE)   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Genetic polymorphisms; Sickle cell anaemia; Stroke; Thalassemia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BILIRUBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; HEMOGLOBIN F; LACTATE DEHYDROGENASE; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALPHA THALASSEMIA; ARTICLE; BRAZIL; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; ERYTHROCYTE COUNT; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; GLOBIN GENE; HAPLOTYPE; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HAPLOTYPES; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; STROKE; YOUNG ADULT;

EID: 84902663035     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2016-1     Document Type: Article

References (55)

1. Cajado C, Cerqueira BA, Couto FD, Moura-Neto JP, Vilas-Boas W, Dorea MJ et al (2011) TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia. Cytokine 56:312-317
2. Steinberg MH (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. Sci World J 9:46-67
3. Stuart MJ, Nagel RL (2004) Sickle-cell disease. Lancet 364:1343-1360 (Pubitemid 39335827)
4. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288-294 (Pubitemid 28018756)
5. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH et al (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639-1644
6. Taylor JG, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, SteinbergMH (2008) Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications andmortalitywith less frequent vasoocclusive pain. PLoS One 3:e2095
7. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP (1997) Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584-1590 (Pubitemid 27509761)
8. Chiang EY, Frenette PS (2005) Sickle cell vaso-occlusion. Hematol Oncol Clin North Am 19:771-784, v (Pubitemid 41427109)
9. Conran N, Franco-Penteado CF, Costa FF (2009) Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 33:1-16
10. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR (1992) Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120:360-366
11. Wang WC, Langston JW, Steen RG, Wynn LW, Mulhern RK, Wilimas JA et al (1998) Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr 132:994-998 (Pubitemid 28280412)
12. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W (1989) Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics 84:500-508 (Pubitemid 19216350)
13. Stockman JA, Nigro MA, Mishkin MM, Oski FA (1972) Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 287:846-849
14. Hoppe C, KlitzW, D'Harlingue K, Cheng S, Grow M, Steiner L et al (2007) Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 38:2241-2246 (Pubitemid 47457562)
15. Adams RJ (2005) TCD in sickle cell disease: an important and useful test. Pediatr Radiol 35:229-234
16. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L et al (2004) Gene interactions and stroke risk in children with sickle cell anemia. Blood 103:2391-2396 (Pubitemid 38326263)
17. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH (2005) Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 37:435-440
18. Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, Simioni P et al (2007) Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38:41-49 (Pubitemid 46035604)
19. Flanagan JM, Frohlich DM, Howard TA, Schultz WH, Driscoll C, Nagasubramanian R et al (2011) Genetic predictors for stroke in children with sickle cell anemia. Blood 117:6681-6684
20. Driscoll MC, Hurlet A, Styles L, McKie V, Files B, Olivieri N et al (2003) Stroke risk in siblings with sickle cell anemia. Blood 101:2401-2404 (Pubitemid 36302088)
21. Kwiatkowski JL, Hunter JV, Smith-Whitley K, Katz ML, Shults J, Ohene-Frempong K (2003) Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br J Haematol 121:932-937 (Pubitemid 36760314)
22. Poggi V, Town M, Foulkes NS, Luzzatto L (1990) Identification of a single base change in a new human mutant glucose-6-phosphate dehydrogenase gene by polymerase-chain-reaction amplification of the entire coding region from genomic DNA. Biochem J 271:157-160 (Pubitemid 20331211)
23. Powars DR (1991) Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am 5:475-493
24. anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 83:105-111
25. Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH (1995) Factor V Leiden (FVQ 506) is common in a Brazilian population. Am J Hematol 49:242-243
26. Data SA, Roltsch MH, Hand B, Ferrell RE, Park JJ, Brown MD (2003) eNOS T-786C genotype, physical activity, and peak forearm blood flow in females. Med Sci Sports Exerc 35:1991-1997 (Pubitemid 37509697)
27. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995) A candidate genetic risk factor for vascular disease: a commonmutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
28. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703 (Pubitemid 26383091)
29. Bandeira FM, Santos MN, Bezerra MA, Gomes YM, Araujo AS, Braga MC et al (2008) Family screening for HBB*S gene and detection of new cases of sickle cell trait in Northeastern Brazil. Rev Saude Publica 42:234-241
30. Bezerra MA, Santos MN, Araujo AS, Gomes YM, Abath FG, Bandeira FM (2007) Molecular variations linked to the grouping of beta- and alpha-globin genes in neonatal patients with sickle cell disease in the state of Pernambuco, Brazil. Hemoglobin 31:83-88
31. Lyra IM, GoncalvesMS, Braga JA,GesteiraMF, CarvalhoMH, Saad ST et al (2005) Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients fromtwo different cities in Brazil. Cad Saude Publica 21:1287-1290
32. Sarnaik SA, Ballas SK (2001) Molecular characteristics of pediatric patients with sickle cell anemia and stroke. Am J Hematol 67:179-182 (Pubitemid 32538616)
33. Sebastiani P, Solovieff N, Hartley SW, Milton JN, Riva A, Dworkis DA et al (2010) Geneticmodifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol 85:29-35
34. Adams RJ, Kutlar A, McKie V, Carl E, Nichols FT, Liu JC et al (1994) Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol 45:279-282 (Pubitemid 24109901)
35. Belisario AR, Rodrigues CV, Martins ML, Silva CM, Viana MB (2010) Coinheritance of alpha-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia. Hemoglobin 34:516-529
36. Hsu LL, Miller ST, Wright E, Kutlar A, McKie V, Wang W et al (2003) Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 25:622-628 (Pubitemid 36959423)
37. Rusanova I, Cossio G,Moreno B, Javier PF, De Borace RG, PereaM et al (2011) β-Globin gene cluster haplotypes in sickle cell patients from Panama. Am J Hum Biol 23:377-380
38. da Silva Filho IL, Leite AC,Moura PG, Ribeiro GS, Cavalcante AC, de Azevedo FC et al (2012) Reply: genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro. Brazil Arq Neuropsiquiatr 70:648-649
39. Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C et al (2008) National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med 148:932-938 (Pubitemid 351860825)
40. Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H et al (2008) Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 148:939-955 (Pubitemid 351860826)
41. SteinbergMH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A et al (2003) Effect of hydroxyurea onmortality andmorbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289:1645-1651 (Pubitemid 37430269)
42. Steinberg MH (2005) Predicting clinical severity in sickle cell anaemia. Br J Haematol 129:465-481
43. Lezcano NE, Odo N, Kutlar A, Brambilla D, Adams RJ (2006) Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke 37:1424-1426 (Pubitemid 44305720)
44. Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W et al (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5-year follow-up. Am J Hematol 85:403-408
45. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P (2007) Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 4:e131
46. Banerjee I, Gupta V, Ganesh S (2007) Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 52:205-219
47. Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61:1652-1661 (Pubitemid 39463422)
48. Bernaudin F, Verlhac S, Chevret S, TorresM, Coic L, Arnaud C et al (2008) G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 112:4314-4317
49. Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE (2007) Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. Am Heart J 153:821-830 (Pubitemid 46602156)
50. Rubattu S, Speranza R, Ferrari M, Evangelista A, BecciaM, Stanzione R et al (2005) A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. Eur J Neurol 12:989-993 (Pubitemid 41820054)
51. Niu PP,YangG, Zheng BK,Guo ZN, Jin H,YangY(2013) Relationship between endothelial nitric oxide synthase gene polymorphisms and ischemic stroke: a meta-analysis. Acta Neurol Scand 128:202-212
52. Li P, Qin C (2013) Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to ischemic stroke: a meta-analysis. Gene 535:359-64
53. Wang M, Jiang X,Wu W, Zhang D (2013) Endothelial NO synthase gene polymorphisms and risk of ischemic stroke in Asian population: a meta-analysis. PLoS One 8:e60472
54. Katusic ZS, Austin SA (2014) Endothelial nitric oxide: protector of a healthy mind. Eur Heart J (in press)
55. Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21:37-47 (Pubitemid 46110926)